Naista Zhand
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
What drives prolonged hospital stays in schizophrenia-spectrum disorders? A Canadian tertiary care review.
Journal: PCN reports : psychiatry and clinical neurosciences
Published: April 08, 2026
Safety of Adjunct Low-Dose Methylphenidate Extended-Release for Cognitive Deficits in Stable Schizophrenia: Results From an Open-Label, Randomized Crossover Trial.
Journal: Journal of clinical psychopharmacology
Published: January 20, 2026
An Exploratory Study of Inflammatory Biomarkers and Extrapyramidal Side Effects in Patients with Schizophrenia.
Journal: Schizophrenia bulletin open
Published: January 01, 2026
Efficacy of Low-Dose Adjunctive Methylphenidate Extended-Release on Cognition and Functioning in Individuals With Schizophrenia: A Randomized Open-Label Trial.
Journal: Journal of clinical psychopharmacology
Published: July 28, 2025
Social cognition among clinical subtypes of schizophrenia.
Journal: Schizophrenia research. Cognition
Published: April 03, 2024
Adjunctive methylphenidate extended release in patients with schizophrenia: Protocol of a single-centre fixed dose cross-over open-label trial to improve functional and cognitive outcomes.
Journal: Contemporary clinical trials communications
Published: December 04, 2023
Mortality Rate and Causes of Death in a Canadian Tertiary Schizophrenia Program.
Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie
Published: August 04, 2023
Pharmacological management of neurocognitive impairment in schizophrenia: A narrative review.
Journal: Neuropsychopharmacology reports
Published: January 23, 2023
Comparison of Extrapyramidal Symptoms Among Outpatients With Schizophrenia on Long-Acting Injectable Antipsychotics.
Journal: Journal of clinical psychopharmacology
Published: August 17, 2022
Limitations of access to antipsychotics in Canada: loss of the old and unavailability of the new options.
Journal: International journal of clinical pharmacy
Published: November 13, 2021
Complete blood count inflammatory markers in treatment-resistant schizophrenia: Evidence of association between treatment responsiveness and levels of inflammation.
Journal: Psychiatry research
Published: October 31, 2021
Retrospective review of use of adjunctive psychostimulants in patients with schizophrenia.
Journal: Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
Published: February 02, 2021
Last Updated: 09/26/2026